KBC Group
INSM icon

KBC Group’s Insmed INSM Stock Holding History

KBC Group’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.42M Buy
38,724
+4,303
+13% +$507K 0.01% 526
2026
Q2 		$3.67M Sell
34,421
-2,926
-8% -$354K 0.01% 567
2026
Q1 		$6.11M Buy
37,347
+3,334
+10% +$513K 0.02% 435
2025
Q4 		$5.92M Buy
34,013
+24,396
+254% +$4.45M 0.01% 437
2025
Q3 		$1.38M Buy
9,617
+4,641
+93% +$569K ﹤0.01% 647
2025
Q2 		$501K Sell
4,976
-2,575
-34% -$197K ﹤0.01% 708
2025
Q1 		$576K Buy
7,551
+678
+10% +$51.9K ﹤0.01% 706
2024
Q4 		$475K Buy
6,873
+2,563
+59% +$185K ﹤0.01% 819
2024
Q3 		$315K Buy
4,310
+730
+20% +$53.9K ﹤0.01% 783
2024
Q2 		$240K Buy
3,580
+405
+13% +$15.7K ﹤0.01% 813
2024
Q1 		$86K Hold
3,175
– – ﹤0.01% 1210
2023
Q4 		$98K Hold
3,175
– – ﹤0.01% 1074
2023
Q3 		$80K Buy
+3,175
New +$72.6K ﹤0.01% 1104

Other funds holding INSM

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

KBC Group's INSM Position: Q3 2026 in Review

KBC Group increased its Insmed (INSM) stake by 13% in Q3 2026, buying an estimated $507K and bringing the position to 38,724 shares worth $4.42M. The position accounts for 0.01% of the portfolio, ranked #526.

KBC Group first reported a position in INSM in Q3 2023 and has held it in 13 quarters since. The position peaked at $6.11M in Q1 2026. 332 funds tracked by Wall St. Rank hold INSM as of Q3 2026.

  • KBC Group held 38,724 shares of Insmed worth $4.42M as of Q3 2026.
  • KBC Group bought 4,303 Insmed shares in Q3 2026, an estimated $507K.
  • Insmed made up 0.01% of KBC Group's portfolio in Q3 2026, its #526 holding.
  • KBC Group first reported a position in Insmed in Q3 2023 and has held it in 13 quarters since.
  • KBC Group's Insmed position peaked at $6.11M in Q1 2026.
  • 332 funds tracked by Wall St. Rank held Insmed as of Q3 2026.

Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.